Population
58 Japanese men with prostate cancer, along with PC3 and LNCaP cell lines.
Design
Other
Authors
Loading...
Elevated CAV1/2 levels associate with CRPC; hypothesis-generating for biomarker or target roles, should not yet change practice.
Plasma CAV1 and CAV2 levels are significantly elevated in castration-resistant prostate cancer, suggesting their potential as therapeutic targets.
Sakabe et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: